APOA1 and gestational diabetes: This is consistent with the established function of apoA-I in facilitating reverse cholesterol transport and its anti-inflammatory properties, which could potentially mitigate GDM risk through enhanced lipid metabolism as well as reduced inflammation [27, 28].